Smoking and mental health - NCSCT

More documents

Recommendations

Info

Smoking and mental health 31 Health and Social Care in Northern Ireland. Northern Ireland Hospital Statistics: Outpatient activity statistics 2009/10 (revised). Belfast: Department of Health, Social Services & Public Safety, 2010. 32 Taylor D, Paton C, Kapur S. The South London and Maudsley & Oxleas NHS Foundation Trust Prescribing Guidelines, 10th edn. London: Informa Healthcare, 2009. 33 Health and Social Care Information Centre. Prescription Cost Analysis England 2010. London: Health and Social Care Information Centre, 2011. 34 British National Formulary. Olanzapine, 2012. www.medicinescomplete.com/mc/ bnf/current/PHP18353-olanzapine-non-proprietary.htm#PHP18353-olanzapine-nonproprietary [Accessed 6 December 2012] 35 Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years’ observations on male British doctors. British Medical Journal 1994;309:901–11. 36 Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. British Medical Journal 2004;328:1519. 37 NHS HSCIC. NHS Outcomes Framework indicators – June 2012 Release, 2012. www.ic.nhs.uk/statistics-and-data-collections/audits-and-performance/nhs-outcomesframework-indicators/nhs-outcomes-framework-indicators—june-2012-release [Accessed 16 November 2012] 38 McManus S, Meltzer H, Brugha T, et al. Adult psychiatric morbidity in England, 2007. Results of a household survey. London: The NHS Information Centre for Health and Social Care, 2009. 39 Office for National Statistics. Population Estimates for UK, England and Wales, Scotland and Northern Ireland – mid 2009. www.ons.gov.uk/ons/publications/re-referencetables.html?edition=tcm%3A77–213645 [Accessed 25 January 2012] 40 American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, 4th edn (DSM-IV). Washington, DC: American Psychiatric Press, 1994. 41 Drummond M, Sculpher MJ, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford: Oxford University Press, 2005. 42 Gray A, Clarke P, Wolstenholme J, et al. Applied methods of cost-effectivenesss analysis in health care. In: Handbooks in Health Economic Evaluation, vol 3. Oxford: Oxford University Press, 2010. 43 NICE. Guide to the methods of technology appraisal. 2008. www.nice.org.uk. 44 Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. Journal of the American Medical Association 1997;278:1759–66. 45 Parrott S, Godfrey C, Raw M, et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. Thorax 1998;53(suppl 5 Pt 2):S1–38. 46 West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000;55:987–99. 47 Woolacott N, Jones L, Forbes CA, et al. The clinical effectiveness and costeffectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation Health Technology Assessment 2002;6:1–245. 48 Shearer J, Shanahan M. Cost effectiveness analysis of smoking cessation interventions. Australian and New Zealand Journal of Public Health 2006;30:428–34. 49 National Institute for Health and Clinical Excellence. NICE public health intervention guidance – Brief interventions and referral for smoking cessation in primary care and other settings. London: NICE, 2006. 50 Britton J, Edwards R.Tobacco smoking, harm reduction, and nicotine product regulation. The Lancet 2008;371:441–5. 180 © Royal College of Physicians 2013
The economic cost of smoking in people with mental disorders 8 51 Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health 2009;9:285. 52 Benowitz NL, Jacob P 3rd. Daily intake of nicotine during cigarette smoking. Clinical Pharmacology and Therapeutics 1984;35:499–504. 53 Henningfield JE. Nicotine medications for smoking cessation. New England Journal of Medicine 1995;333:1196–203. 54 The Tobacco Advisory Group of the Royal College. Harm reduction in nicotine addiction Helping people who can’t quit. London: Royal College of Physicians of London, 2007. 55 The Royal College of Physicians. Ending tobacco smoking in Britain, Radical strategies for prevention and harm reduction in nicotine addiction. A report by the Tobacco Advisory Group of the Royal College of Physicians. London: RCP, 2008. 56 Wang D, et al. ‘Cut down to quit’ with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technology Assessment 2008;12(2):38. © Royal College of Physicians 2013 181
Page 1 and 2:
PDF not for circulation Smoking and
Page 3 and 4:
Contents Members of the Tobacco Adv
Page 5 and 6:
Contents 4.4.3 Attention deficit hy
Page 7 and 8:
Contents 6.4.3 Staff knowledge 122
Page 9 and 10:
Contents 10.5 Tobacco policy and me
Page 11 and 12:
Contributors Anthony Aclet - Specia
Page 13 and 14:
Contributors Jill Williams - Associ
Page 15 and 16:
1 Mental disorders 1.1 What is a me
Page 17 and 18:
Mental disorders 1 1.3 Common menta
Page 19 and 20:
Mental disorders 1 1.4.4 Somatisati
Page 21 and 22:
Mental disorders 1 In addition to s
Page 23 and 24:
Mental disorders 1 not diagnosed un
Page 25 and 26:
Mental disorders 1 Similar to many
Page 27 and 28:
Mental disorders 1 12 Chang CK, Hay
Page 29 and 30:
Mental disorders 1 52 Young S, Toon
Page 31 and 32:
Smoking among people with mental di
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Neurobiological and behavioural mec
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Epidemiology of the association bet
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Smoking cessation interventions for
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
6 Population strategies to prevent
Page 127 and 128:
Population strategies to prevent sm
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144: Population strategies to prevent sm
Page 145 and 146: Smoking and mental disorders: speci
Page 179 and 180: The economic cost of smoking in peo
Page 193: The economic cost of smoking in peo
Page 197 and 198: Ethical and legal aspects 9 pose co
Page 199 and 200: Ethical and legal aspects 9 less an
Page 201 and 202: Ethical and legal aspects 9 patient
Page 203 and 204: 10 Summary and conclusions 10.1 Smo
Page 205 and 206: Summary and conclusions 10 10.4 Smo
Page 207 and 208: Summary and conclusions 10 although
Page 209 and 210: 11 Key conclusions and recommendati
Page 211 and 212: Key conclusions and recommendations
Page 213 and 214: Key conclusions and recommendations
Page 215: Key conclusions and recommendations
show all

Smoking and mental health - NCSCT

Create successful ePaper yourself

Delete template?

Save as template?